[Davide]

For the information in my possession always talking to researchers and doctors, oveloxone could really be a turning point as well as it could do little in people with more years of Ataxia, I explain better: the drug experimentation was done on people who were “better” because they had to meet high standards, as soon as (I hope as possible) it will be marketed everyone can use it and here it is not known how it will react, it could give limited results in those who are worse than those who have experienced it but for the same reasoning it was explained to me by a researcher in Milan that it could even have more important results in those who have the disease for longer